Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 2 , Pages 216-224, June 2009

Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region

Department of Pharmaceutical Sciences and Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Massachusetts, USA

Received 8 July 2008; accepted 14 October 2008. published online 06 November 2008.

Abstract 

Near-infrared (NIR) whole-body imaging is a powerful noninvasive method for the visualization of complex biological phenomena such as tumor and tumor vasculature and for whole-body studies. In this study we introduced a new NIR contrast agent in poly(ethylene glycol)-phospholipid micelle-encapsulated quantum dots (QD-Ms). QD-Ms maximally accumulated in the tumor area within 1 hour as compared to 4 hours for the commercially available PEGylated quantum dots (QD-PEGs) and allowed for the visualization of both tumor and internal organs. QD-Ms showed a signal-to-noise ratio of 15 that allowed the quantification of the micelles' biodistribution using image analysis. The signal obtained with the QD-Ms was higher than with the commercial formulation at half the QD dose. Overall, the QD-Ms seem to be a powerful and rapidly acting nanosized imaging agent that allows for effective visualization of tumors using NIR imaging.

Key words: Nanosized imaging agents, Polymeric micelles, Near-infrared whole-body imaging, Tumor-imaging quantum dots, Contrast agents

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by National Institutes of Health grant RO1 EB001961 to V.P. Torchilin.

PII: S1549-9634(08)00181-0

doi:10.1016/j.nano.2008.10.001

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 2 , Pages 216-224, June 2009